Press Releases

InVivo Therapeutics Co-Founder Dr. Robert Langer to Highlight InVivo Scientific Progress in Keynote at 2015 TERMIS World Congress

Published: September 2, 2015

- Dr. Alex Aimetti to Speak on Clinical Translation Panel – CAMBRIDGE, Mass. (Sept 2, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) has announced that Co- Founder Robert Langer, Sc.D., will make a keynote address and highlight InVivo’s scientific progress at the 2015 Tissue Engineering & Regenerative Medicine International Society (TERMIS) World Congress in Boston on Wednesday, September 9, 2015. On the same day, Alex Aimetti, Ph.D., Senior Director, Medical Education and Scientific Support at InVivo, will participate in a clinical translation panel titled “Strategies for Translating Promising Academic Tissue Engineering Concepts to Successful Products.” Other panelists include David Kaplan, […]

View Article
InVivo Therapeutics to Present at Rodman & Renshaw 17th Annual Global Investment Conference

Published: September 1, 2015

CAMBRIDGE, Mass. (Sept 1, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that Mark Perrin, Chief Executive Officer and Chairman, is scheduled to present at the Rodman & Renshaw 17th Annual Global Investment Conference to be held September 8-10, 2015 at the St. Regis Hotel in New York City, NY. The company’s presentation will be Thursday, September 10 at 1:45 PM (EDT). A live webcast will be available at http://wsw.com/webcast/rrshq25/nviv. Mr. Perrin said, “I am pleased to be presenting at the Rodman & Renshaw Conference again this year. Last year served as a valuable platform to communicate the InVivo […]

View Article
InVivo Therapeutics to Present at 2015 Tissue Engineering & Regenerative Medicine International Society World Congress

Published: August 31, 2015

CAMBRIDGE, Mass. (August 31, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that the abstract “Biodegradable Neuro-Spinal Scaffold Preserves Macroscopic Spinal Cord Architecture and Allows for Neural Regeneration at the Spinal Cord Contusion Epicenter” has been accepted for presentation at the 2015 Tissue Engineering & Regenerative Medicine International Society (TERMIS) World Congress to be held September 8-11, 2015 in Boston, MA. Alex Aimetti, Ph.D., Senior Director, Medical Education and Scientific Support, will be giving the poster presentation. The abstract is co- authored by Dr. Aimetti, Richard Layer, Ph.D., Simon Moore, Ph.D., and Thomas Ulich, M.D. Mark Perrin, InVivo’s CEO […]

View Article
InVivo Therapeutics to Present at the 17th Annual Spinal Research Network Meeting

Published: August 25, 2015

CAMBRIDGE, Mass. (August 25, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that Alex Aimetti, Ph.D., Senior Director, Medical Education and Scientific Support, will be giving a poster presentation at the 17th Annual Spinal Research Network Meeting to be held September 4-5, 2015 in London, UK. The abstract, titled “Benefits of Surgical Implantation of an Investigational Biodegradable Neuro-Spinal Scaffold in Various Animal Models of Acute Spinal Cord Contusion Injury: Clinical Translation,” is co-authored by Dr. Aimetti, James Guest, M.D., Nicholas Theodore, M.D., Domagoj Coric, M.D., Lorianne Masuoka, M.D., Simon Moore, Ph.D., Richard Layer, Ph.D., and Thomas Ulich, M.D. “This […]

View Article
InVivo Therapeutics Announces Listing Transfer to Nasdaq Global Market

Published: August 24, 2015

CAMBRIDGE, Mass. (August 24, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that the listing of the company’s common stock has been transferred to the Nasdaq Global Market. The company’s common stock previously traded on the Nasdaq Capital Market and will continue to trade under the same symbol NVIV. This follows the July 29th announcement by InVivo that the company has been added to the Russell Global, Russell 3000®, Russell 2000®, and Russell Microcap indexes. Mark Perrin, InVivo’s CEO and Chairman, said, “This move to the higher Nasdaq Global Market tier is a reflection of the fundamental health of […]

View Article
InVivo Therapeutics Featured in Front Page Article in The Boston Globe

Published: August 24, 2015

CAMBRIDGE, Mass. (August 24, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) has announced that the company and the company’s ongoing trial of its investigational Neuro-Spinal Scaffold in patients with acute thoracic spinal cord injury were featured in a front page article in The Boston Globe on Sunday, August 23. The article was published on the front page of The Boston Globe’s website (www.bostonglobe.com) on Friday, August 21. The story was produced by Stat, a new national publication from Boston Globe Media Partners that will launch this fall with coverage of health, medicine, and life sciences. The Boston Globe reaches over […]

View Article
InVivo Therapeutics Announces Enrollment of Fourth Patient in Pilot Spinal Cord Injury Trial

Published: August 20, 2015

CAMBRIDGE, Mass. (August 20, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that a fourth patient has been enrolled in the company’s ongoing pilot trial of its investigational Neuro- Spinal Scaffold in patients with acute thoracic spinal cord injury at the UC Davis Medical Center in Sacramento, CA. Kee Kim, M.D., Principal Investigator at this site, performed the fourth-ever Neuro-Spinal Scaffold implantation approximately 53 hours after the injury occurred. Mark Perrin, InVivo’s CEO and Chairman, said, “We continue to make meaningful progress in our ongoing clinical trial. With the fourth patient successfully enrolled, we look forward to enrolling the […]

View Article
InVivo Therapeutics’ CEO and Chairman, Mark Perrin, Interviewed by Maria Bartiromo on FOX Business Network’s “Mornings with Maria”

Published: August 13, 2015

CAMBRIDGE, Mass. (August 13, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that Mark Perrin, Chief Executive Officer and Chairman of the Board, appeared on the Fox Business Network program “Mornings with Maria” on Thursday, August 13. The program, anchored by FOX Business Global Markets Editor Maria Bartiromo, runs weekdays from 6-9 A.M. (ET) and reaches an estimated 5.3 million viewers. The groundbreaking financial journalist covers the day’s top business news and interviews leaders of some of the world’s largest companies. “I am very pleased to have appeared on this widely viewed program with Maria,” Mr. Perrin said. “We see […]

View Article
InVivo Therapeutics Announces New Jersey’s Cooper Neurological Institute as New Clinical Site for Neuro-Spinal Scaffold

Published: August 12, 2015

CAMBRIDGE, Mass. (August 12, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Cooper Neurological Institute (CNI) in Camden, NJ has been added as a clinical site in the company’s ongoing pilot study of its investigational Neuro-Spinal Scaffold in patients with acute spinal cord injury (SCI). CNI is a part of Cooper University Health Care, a network providing care to Southern New Jersey and the entire Delaware Valley. Steven Yocom, DO, Assistant Professor of Neurosurgery and Co-Director of the CNI Spine Program, has been named Principal Investigator at this site. “Our group has a particular interest in spinal […]

View Article
InVivo Therapeutics Announces Promotions and New Organizational Roles to Further Drive Market Development and Awareness of Spinal Cord Injury Innovation

Published: August 6, 2015

CAMBRIDGE, Mass. (August 6, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced promotions for two members of its management team. Christopher McNulty has been appointed as Senior Vice President, Business Development and Investor Relations. He will continue to lead all business development and corporate communications efforts, including investor relations and public relations. This role is a promotion from his previous role as Vice President, Business Development and Investor Relations. Before coming to InVivo in November 2013, Mr. McNulty served as Senior Director of Business Development at Repligen Corporation. Previously, he was Director of Corporate Development at Seventh Sense Biosystems, and Associate Director of Business Development […]

View Article

The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on the InVivo website for historical purposes only. InVivo assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.